Literature DB >> 2580816

The use of antibodies to intermediate filament proteins in the differential diagnosis of lymphoma versus metastatic carcinoma.

F C Ramaekers, T M Vroom, O Moesker, A Kant, G Scholte, G P Vooijs.   

Abstract

Forty-nine cases encompassing 16 different types of malignant lymphoma were examined for their intermediate filament protein (IFP) type by indirect immunofluorescence microscopy of cryostat sections. In all cases, vimentin was shown to be the only IFP type detectable in these tumours. Lymphomas are negative for keratin and desmin, which are characteristic for benign and malignant epithelial or muscular tissues respectively. In addition, eighteen cases are described in which antibodies to intermediate filament proteins were used successfully to distinguish between lymphoma and metastatic carcinoma where differential diagnosis was difficult or impossible on the basis of routine histology.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580816     DOI: 10.1007/bf01003403

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  27 in total

1.  Keratin cytoskeletons in epithelial cells of internal organs.

Authors:  T T Sun; C Shih; H Green
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

Review 2.  Identification and characterization of epithelial cells in mammalian tissues by immunofluorescence microscopy using antibodies to prekeratin.

Authors:  W W Franke; B Appelhans; E Schmid; C Freudenstein; M Osborn; K Weber
Journal:  Differentiation       Date:  1979       Impact factor: 3.880

3.  Immunogenic properties of the glial fibrillary acidic protein.

Authors:  D Dahl; A Bignami
Journal:  Brain Res       Date:  1976-10-29       Impact factor: 3.252

4.  Intermediate filaments.

Authors:  M Osborn; N Geisler; G Shaw; G Sharp; K Weber
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1982

5.  Mesodermal mixed tumor. Diagnosis by analysis of intermediate filament proteins.

Authors:  F C Ramaekers; R H Verheijen; O Moesker; A Kant; G P Vooijs; C J Herman
Journal:  Am J Surg Pathol       Date:  1983-06       Impact factor: 6.394

6.  Intermediate filaments as mechanical integrators of cellular space.

Authors:  E Lazarides
Journal:  Nature       Date:  1980-01-17       Impact factor: 49.962

7.  Intermediate filaments in malignant melanomas. Identification and use as marker in surgical pathology.

Authors:  F C Ramaekers; J J Puts; O Moesker; A Kant; G P Vooijs; P H Jap
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

8.  Complex cytokeratin polypeptide patterns observed in certain human carcinomas.

Authors:  R Moll; R Krepler; W W Franke
Journal:  Differentiation       Date:  1983       Impact factor: 3.880

9.  A malignant tumor arising from interdigitating cells; light microscopical, ultrastructural, immuno-and enzyme-histochemical characteristics.

Authors:  C A Feltkamp; P van Heerde; T M Feltkamp-Vroom; J Koudstaal
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

Review 10.  Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview.

Authors:  F C Ramaekers; J J Puts; O Moesker; A Kant; A Huysmans; D Haag; P H Jap; C J Herman; G P Vooijs
Journal:  Histochem J       Date:  1983-07
View more
  3 in total

1.  Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas.

Authors:  C Gustmann; M Altmannsberger; M Osborn; H Griesser; A C Feller
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

2.  Antibodies to cytokeratin and vimentin in testicular tumour diagnosis.

Authors:  F Ramaekers; W Feitz; O Moesker; G Schaart; C Herman; F Debruyne; P Vooijs
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

Review 3.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.